These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
503 related items for PubMed ID: 9467543
1. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty. Boot AM, De Muinck Keizer-Schrama S, Pols HA, Krenning EP, Drop SL. J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543 [Abstract] [Full Text] [Related]
2. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. van der Sluis IM, Boot AM, Krenning EP, Drop SL, de Muinck Keizer-Schrama SM. J Clin Endocrinol Metab; 2002 Feb; 87(2):506-12. PubMed ID: 11836277 [Abstract] [Full Text] [Related]
3. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM. J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311 [Abstract] [Full Text] [Related]
4. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment. Lem AJ, van der Kaay DC, Hokken-Koelega AC. J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290 [Abstract] [Full Text] [Related]
5. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Mengarda F, Pietrobelli A, Tatò L. J Clin Endocrinol Metab; 2003 Mar; 88(3):1096-101. PubMed ID: 12629090 [Abstract] [Full Text] [Related]
6. Changes in bone mineral density and body composition in children with central precocious puberty and early puberty before and after one year of treatment with GnRH agonist. Ko JH, Lee HS, Lim JS, Kim SM, Hwang JS. Horm Res Paediatr; 2011 Mar; 75(3):174-9. PubMed ID: 20881364 [Abstract] [Full Text] [Related]
7. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Högler W, Briody J, Moore B, Lu PW, Cowell CT. Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578 [Abstract] [Full Text] [Related]
8. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment. Antoniazzi F, Bertoldo F, Lauriola S, Sirpresi S, Gasperi E, Zamboni G, Tatò L. J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699 [Abstract] [Full Text] [Related]
9. Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism. Takahashi Y, Minamitani K, Kobayashi Y, Minagawa M, Yasuda T, Niimi H. J Clin Endocrinol Metab; 1996 Mar; 81(3):1248-53. PubMed ID: 8772607 [Abstract] [Full Text] [Related]
10. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study. Lanes R, Gunczler P, Esaa S, Weisinger JR. Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321 [Abstract] [Full Text] [Related]
11. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature. Kapteijns-van Kordelaar S, Noordam K, Otten B, van den Bergh J. Eur J Pediatr; 2003 Nov; 162(11):776-80. PubMed ID: 13680381 [Abstract] [Full Text] [Related]
12. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW. J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865 [Abstract] [Full Text] [Related]
13. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. Heger S, Partsch CJ, Sippell WG. J Clin Endocrinol Metab; 1999 Dec; 84(12):4583-90. PubMed ID: 10599723 [Abstract] [Full Text] [Related]
14. Bone mineral density and body composition in Thai Precocious Puberty girls treated with GnRH agonist. Wacharasindhu S, Petwijit T, Aroonparkmongkol S, Srivuthana S, Kingpetch K. J Med Assoc Thai; 2006 Aug; 89(8):1194-8. PubMed ID: 17048429 [Abstract] [Full Text] [Related]
16. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency. Gonc EN, Kandemir N. Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489 [Abstract] [Full Text] [Related]
17. Evaluation of bone density in girls with precocious and early puberty during treatment with GnRH agonist. Assa A, Weiss M, Aharoni D, Mor A, Rachmiel M, Bistritzer T. J Pediatr Endocrinol Metab; 2011 May; 24(7-8):505-10. PubMed ID: 21932589 [Abstract] [Full Text] [Related]
19. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R. J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790 [Abstract] [Full Text] [Related]